Your browser doesn't support javascript.
loading
High level efficacy of lufenuron against sea lice (Lepeophtheirus salmonis) linked to rapid impact on moulting processes.
Poley, Jordan D; Braden, Laura M; Messmer, Amber M; Igboeli, Okechukwu O; Whyte, Shona K; Macdonald, Alicia; Rodriguez, Jose; Gameiro, Marta; Rufener, Lucien; Bouvier, Jacques; Wadowska, Dorota W; Koop, Ben F; Hosking, Barry C; Fast, Mark D.
Afiliação
  • Poley JD; Hoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: jpoley@upei.ca.
  • Braden LM; Hoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: lbraden@upei.ca.
  • Messmer AM; Centre for Biomedical Research, Department of Biology, University of Victoria, Victoria BC, V8W 3N5, Canada. Electronic address: amessmer@uvic.ca.
  • Igboeli OO; Hoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: oigboeli@gmail.com.
  • Whyte SK; Hoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: swhyte@upei.ca.
  • Macdonald A; Elanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: alicia.macdonald@elanco.com.
  • Rodriguez J; Elanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: jose.rodriguez@elanco.com.
  • Gameiro M; Elanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: marta.gameiro@elanco.com.
  • Rufener L; Elanco Centre de Recherche Santé Animale SA, CH-1566 St.-Aubin, Switzerland; INVENesis LLC, Chemin de Belleroche 14, 2000 Neuchâtel, Switzerland. Electronic address: lucien.rufener@elanco.com.
  • Bouvier J; Elanco Centre de Recherche Santé Animale SA, CH-1566 St.-Aubin, Switzerland; INVENesis LLC, Chemin de Belleroche 14, 2000 Neuchâtel, Switzerland. Electronic address: jacques.bouvier@elanco.com.
  • Wadowska DW; Electron Microscopy Laboratory, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown, PEI, C1A 4P3, Canada. Electronic address: Wadowska@upei.ca.
  • Koop BF; Centre for Biomedical Research, Department of Biology, University of Victoria, Victoria BC, V8W 3N5, Canada. Electronic address: bkoop@uvic.ca.
  • Hosking BC; Elanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: barry.hosking@elanco.com.
  • Fast MD; Hoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: mfast@upei.ca.
Int J Parasitol Drugs Drug Resist ; 8(2): 174-188, 2018 08.
Article em En | MEDLINE | ID: mdl-29627513
ABSTRACT
Drug resistance in the salmon louse Lepeophtheirus salmonis is a global issue for Atlantic salmon aquaculture. Multiple resistance has been described across most available compound classes with the exception of the benzoylureas. To target this gap in effective management of L. salmonis and other species of sea lice (e.g. Caligus spp.), Elanco Animal Health is developing an in-feed treatment containing lufenuron (a benzoylurea) to be administered prior to seawater transfer of salmon smolts and to provide long-term protection of salmon against sea lice infestations. Benzoylureas disrupt chitin synthesis, formation, and deposition during all moulting events. However, the mechanism(s) of action are not yet fully understood and most research completed to date has focused on insects. We exposed the first parasitic stage of L. salmonis to 700 ppb lufenuron for three hours and observed over 90% reduction in survival to the chalimus II life stage on the host, as compared to vehicle controls. This agrees with a follow up in vivo administration study on the host, which showed >95% reduction by the chalimus I stage. Transcriptomic responses of salmon lice exposed to lufenuron included genes related to moulting, epithelial differentiation, solute transport, and general developmental processes. Global metabolite profiles also suggest that membrane stability and fluidity is impacted in treated lice. These molecular signals are likely the underpinnings of an abnormal moulting process and cuticle formation observed ultrastructurally using transmission electron microscopy. Treated nauplii-staged lice exhibited multiple abnormalities in the integument, suggesting that the coordinated assembly of the epi- and procuticle is impaired. In all cases, treatment with lufenuron had rapid impacts on L. salmonis development. We describe multiple experiments to characterize the efficacy of lufenuron on eggs, larvae, and parasitic stages of L. salmonis, and provide the most comprehensive assessment of the physiological responses of a marine arthropod to a benzoylurea chemical.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Benzamidas / Muda / Salmo salar / Ftirápteros Limite: Animals Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Benzamidas / Muda / Salmo salar / Ftirápteros Limite: Animals Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2018 Tipo de documento: Article